1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. CORCEPT THERAPEUTICS INC
Corcept Therapeutics Inc XNAS: CORT

Corcept Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Slowing Down Stock
about

Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol. The ...

Read More
42.52 1.22 (2.95%)
63.76% Fall from 52W High
211.7K
XNAS Volume

XNAS 23 Jan, 2026 9:44 AM (EST)

Watchlist

Portfolio

Alert
Positive Trial
Corcept rises on Thursday after late-stage trial shows its drug cuts death risk from ovarian cancer See details
Durability score
Medium Financial Strength
44.4 / 100
Valuation Score
Mid Valuation
37.3 / 100
Momentum Score
Technically Bearish
28.5 / 100
Slowing Down Stock These stocks have medium financials and valuations, but weak momentum indicating decreasing investor interest View Similar Embed DVM
Analyst Price Target
91
1Yr Price target upside is 114%
5 analysts

16

S

13

W

3

O

2

T

SWOT Analysis

Corcept Therapeutics Inc Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..